|
21 Companies |
|
15 Products |
|
15 Products |
|
14 Mechanisms of Action |
|
0 Trials |
|
73 News |
|
| 12» |
- | Trial completion date, Trial primary completion date: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Oct 1, 2024
P=N/A, N=90, Active, not recruiting, Sponsor: Jonsson Comprehensive Cancer Center
Trial completion date: Jul 2025 --> Jul 2026 | Trial primary completion date: Jul 2024 --> Jul 2025
- | Trial completion date, Trial primary completion date: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Sep 15, 2023
P=N/A, N=90, Active, not recruiting, Sponsor: Jonsson Comprehensive Cancer Center
Trial completion date: Jul 2025 --> Jul 2026 | Trial primary completion date: Jul 2024 --> Jul 2025 Trial completion date: Jul 2024 --> Jul 2025 | Trial primary completion date: Jul 2023 --> Jul 2024
- | Enrollment closed, Trial completion date, Trial primary completion date: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms (clinicaltrials.gov) - Mar 14, 2023
P=N/A, N=90, Active, not recruiting, Sponsor: Jonsson Comprehensive Cancer Center
Trial completion date: Jul 2024 --> Jul 2025 | Trial primary completion date: Jul 2023 --> Jul 2024 Completed --> Active, not recruiting | Trial completion date: Jul 2012 --> Jul 2024 | Trial primary completion date: Jul 2012 --> Jul 2023
- | NN1213 / Novo Nordisk
Enrollment change, Trial termination: Self-Help Video for Insomnia in College Students (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=32, Terminated, Sponsor: University of Alabama, Tuscaloosa
Completed --> Active, not recruiting | Trial completion date: Jul 2012 --> Jul 2024 | Trial primary completion date: Jul 2012 --> Jul 2023 N=50 --> 32 | Suspended --> Terminated; Lack of participants
- | Trial completion: Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease (clinicaltrials.gov) - Oct 3, 2018
P=N/A, N=118, Completed, Sponsor: Stanford University
N=50 --> 32 | Suspended --> Terminated; Lack of participants Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Treatment for Insomnia During Pregnancy (clinicaltrials.gov) - Jul 23, 2018
P=N/A, N=194, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Mar 2018
- |||| eszopiclone / Generic mfg., fluoxetine / Generic mfg.
Trial completion, Enrollment change: Improving Sleep and Psychological Functioning in People With Depression and Insomnia (clinicaltrials.gov) - Dec 19, 2017
P4, N=60, Completed, Sponsor: Wake Forest University Health Sciences
Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Mar 2018 Active, not recruiting --> Completed | N=96 --> 60
- | Phase classification: Adding Sleep Intervention to Traditional Diet and Exercise Approach to Weight Loss (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=28, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed | N=96 --> 60 Phase classification: P2 --> P=N/A
- | Enrollment closed, Phase classification, Trial primary completion date: Treatment for Insomnia During Pregnancy (clinicaltrials.gov) - Apr 16, 2017
P=N/A, N=184, Active, not recruiting, Sponsor: Stanford University
Phase classification: P2 --> P=N/A Recruiting --> Active, not recruiting | Phase classification: P2/3 --> PN/A | Trial primary completion date: Dec 2017 --> Mar 2018
- Trial primary completion date: Treatment for Insomnia During Pregnancy (clinicaltrials.gov) - Nov 3, 2016
P2/3, N=184, Recruiting, Sponsor: Stanford University
Recruiting --> Active, not recruiting | Phase classification: P2/3 --> PN/A | Trial primary completion date: Dec 2017 --> Mar 2018 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion: SHUTiNorse: Internet-based Treatment for Insomnia (clinicaltrials.gov) - Aug 30, 2016
P=N/A, N=200, Completed, Sponsor: Norwegian Institute of Public Health
Trial primary completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Completed
- Enrollment change, Real-world evidence, Real-world: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (clinicaltrials.gov) - Aug 16, 2016
P=N/A, N=907, Completed, Sponsor: University of Missouri-Columbia
Active, not recruiting --> Completed N=728 --> 907
- | Trial completion, Enrollment change, Trial primary completion date: Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients (clinicaltrials.gov) - Aug 16, 2016
P=N/A, N=40, Completed, Sponsor: Lacrima Medical LTD
N=728 --> 907 Recruiting --> Completed | N=70 --> 40 | Trial primary completion date: Jun 2017 --> Jul 2016
- Trial completion, Enrollment change, Trial primary completion date: Sleep Disorders Management, Health and Safety in Police (clinicaltrials.gov) - Mar 19, 2016
P=N/A, N=731, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed | N=70 --> 40 | Trial primary completion date: Jun 2017 --> Jul 2016 Active, not recruiting --> Completed | N=2400 --> 731 | Trial primary completion date: Dec 2015 --> Sep 2010
- || Enrollment change, Trial primary completion date: Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients (clinicaltrials.gov) - Mar 8, 2016
P=N/A, N=70, Recruiting, Sponsor: Lacrima Medical LTD
Active, not recruiting --> Completed | N=2400 --> 731 | Trial primary completion date: Dec 2015 --> Sep 2010 N=40 --> 70 | Trial primary completion date: Aug 2016 --> Jun 2017
- ||||||| gaboxadol (OV101) / Ovid Therapeutics, Healx
Trial completion: Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) (clinicaltrials.gov) - Feb 27, 2016
P3, N=465, Completed, Sponsor: H. Lundbeck A/S
N=40 --> 70 | Trial primary completion date: Aug 2016 --> Jun 2017 No longer recruiting --> Completed
- | Trial completion, Trial primary completion date: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Jan 30, 2016
P2/3, N=111, Completed, Sponsor: Duke University
No longer recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Feb 2011
- | Trial completion, Trial primary completion date: SHUTi: An Interactive Internet Intervention for Adults With Insomnia (clinicaltrials.gov) - Jan 11, 2016
P3, N=303, Completed, Sponsor: University of Virginia
Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Feb 2011 Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Oct 2014
- Enrollment open: Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=40, Recruiting, Sponsor: VA Office of Research and Development
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Oct 2014 Active, not recruiting --> Recruiting
- Trial primary completion date: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Nov 15, 2015
P2/3, N=111, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Recruiting Trial primary completion date: Oct 2015 --> Oct 2016
- eszopiclone / Generic mfg.
Trial termination: How do Sleeping Pills Affect Pain in the Brain? (clinicaltrials.gov) - Oct 26, 2015
P4, N=40, Terminated, Sponsor: University of California, San Diego
Trial primary completion date: Oct 2015 --> Oct 2016 Completed --> Terminated; Funding terminated by sponsor, insufficient data collection
- Trial primary completion date: SHUTiNorse: Internet-based Treatment for Insomnia (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=200, Active, not recruiting, Sponsor: Norwegian Institute of Public Health
Completed --> Terminated; Funding terminated by sponsor, insufficient data collection Trial primary completion date: Dec 2014 --> Dec 2015
- Enrollment closed: Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia (clinicaltrials.gov) - Jun 25, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Department of Veterans Affairs
Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting
- |||| Trial primary completion date: Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia (clinicaltrials.gov) - Dec 5, 2014
P2/3, N=111, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Trial primary completion date: Oct 2014 --> Oct 2015
- Enrollment open: Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=40, Recruiting, Sponsor: Lacrima Medical LTD
Trial primary completion date: Oct 2014 --> Oct 2015 Not yet recruiting --> Recruiting
- Enrollment change: Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder (clinicaltrials.gov) - Nov 17, 2014
P=N/A, N=35, Completed, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting N=25 --> 35
- Enrollment closed: SHUTiNorse: Internet-based Treatment for Insomnia (clinicaltrials.gov) - Oct 11, 2014
P=N/A, N=200, Active, not recruiting, Sponsor: Norwegian Institute of Public Health
N=25 --> 35 Not yet recruiting --> Active, not recruiting
- Clinical: Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=40, Not yet recruiting, Sponsor: Lacrima Medical LTD
- ||||| Lendormin (brotizolam) / Boehringer Ingelheim
New P4 trial: Lendormin D (clinicaltrials.gov) - Aug 22, 2014
P4, N=485, Completed, Sponsor: Boehringer Ingelheim
- eszopiclone / Generic mfg.
Trial completion: How do Sleeping Pills Affect Pain in the Brain? (clinicaltrials.gov) - Aug 5, 2014
P4, N=0, Completed, Sponsor: University of California, San Diego
Not yet recruiting --> Active, not recruiting Recruiting --> Completed
- New P3 trial: Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia (clinicaltrials.gov) - Jul 8, 2014
P3, N=49, Terminated, Sponsor: Boehringer Ingelheim
- |||||||||| New P3 trial: The Ability of Songha Night (clinicaltrials.gov) - Jul 8, 2014
P3, N=146, Completed, Sponsor: Boehringer Ingelheim
- Enrollment open: Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia (clinicaltrials.gov) - Jun 17, 2014
P=N/A, N=40, Recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Not yet recruiting --> Recruiting
- cyclobenzaprine / Generic mfg.
Trial primary completion date: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (clinicaltrials.gov) - May 18, 2014
P2, N=2, Terminated, Sponsor: Lynn Henry
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2014 --> May 2014
- cyclobenzaprine / Generic mfg.
Trial termination: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (clinicaltrials.gov) - May 18, 2014
P2, N=2, Terminated, Sponsor: Lynn Henry
Trial primary completion date: Oct 2014 --> May 2014 Recruiting --> Terminated; Accrual terminated early because of poor accrual
- cyclobenzaprine / Generic mfg.
Trial completion date: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (clinicaltrials.gov) - May 18, 2014
P2, N=2, Terminated, Sponsor: Lynn Henry
Recruiting --> Terminated; Accrual terminated early because of poor accrual Trial completion date: Mar 2015 --> Sep 2014
- cyclobenzaprine / Generic mfg.
Enrollment change: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (clinicaltrials.gov) - May 18, 2014
P2, N=2, Terminated, Sponsor: Lynn Henry
Trial completion date: Mar 2015 --> Sep 2014 N=36 --> 2
- |||||||||| Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
New P3 trial: Efficacy and Safety of KI1001 in the Treatment of ? 55 Years Old Insomnia Patients (clinicaltrials.gov) - Mar 12, 2014
P3, N=80, Completed, Sponsor: Kuhnil Pharmaceutical Co., Ltd.
- | modafinil / Generic mfg.
Trial completion: The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia (clinicaltrials.gov) - Feb 22, 2014
P4, N=40, Completed, Sponsor: University of Rochester
N=36 --> 2 Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Effects of Valerian on Sleep in Healthy Older Adults (clinicaltrials.gov) - Feb 22, 2014
P2, N=18, Completed, Sponsor: University of Washington
Recruiting --> Completed No longer recruiting --> Completed
- | Enrollment closed: TRIAD - Treatment of Insomnia and Depression (clinicaltrials.gov) - Nov 26, 2013
P2/3, N=216, Active, not recruiting, Sponsor: Stanford University
No longer recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Trial completion: Comparison of Two Temperatures to Treat Insomnia (clinicaltrials.gov) - Sep 16, 2013
P=N/A, N=144, Completed, Sponsor: Cereve, Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: Combined Behavioral/Pharmacological Therapy for Insomnia (clinicaltrials.gov) - Sep 11, 2013
P2, N=162, Completed, Sponsor: Duke University
Recruiting --> Completed Recruiting --> Completed
- Video: Self-Help Video for Insomnia in College Students (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=50, Suspended, Sponsor: University of Alabama, Tuscaloosa
- cyclobenzaprine / Generic mfg.
New P2 trial: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients (clinicaltrials.gov) - Aug 11, 2013
P2, N=36, Recruiting, Sponsor: Lynn Henry
- Enrollment change: Comprehensive Police Fatigue Management Program (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=683, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed N=3600 --> 683
- Enrollment closed: Sleep Disorders Management, Health and Safety in Police (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=2400, Active, not recruiting, Sponsor: Brigham and Women's Hospital
N=3600 --> 683 Recruiting --> Active, not recruiting
- Trial completion: Comprehensive Police Fatigue Management Program (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=683, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Enrollment change: TRIAD - Treatment of Insomnia and Depression (clinicaltrials.gov) - Jul 15, 2013
P2/3, N=216, Active, not recruiting, Sponsor: Stanford University
Active, not recruiting --> Completed N=320 --> 216
- |||| piromelatine (Neu P11) / Neurim
Trial completion: Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients (clinicaltrials.gov) - Jul 14, 2013
P2, N=137, Completed, Sponsor: Neurim Pharmaceuticals Ltd.
N=320 --> 216 Active, not recruiting --> Completed